Mangalam Drugs commissions intermediate manufacturing facility
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
The GMP certificate is valid for three years until April 2024.
Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.
As the Clinical Head of Oncology Network, he lead a team of over 25 specialised oncologists
PMDA is regarded among the most stringent regulatory bodies globally
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The company allocated €56 million to research and development for next-generation line solutions
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Subscribe To Our Newsletter & Stay Updated